Skip to main content
    H

    HCA Healthcare, Inc. (HCA)

    Official site

    HEALTHCARE • MEDICAL CARE FACILITIES • NYSE

    $511.78
    +12.73 (+2.55%)

    Market Cap: $104.25B

    Last updated: Nov 17, 2026 at 11:06 AM ET

    HCA Healthcare, Inc. (HCA) Stock Forecast

    Updated Nov 17, 2026. Estimates and ratings come from consensus analyst data.

    Analysts expect HCA Healthcare (HCA) to earn $30.16 per share in the fiscal year ending Dec 31, 2026, on revenue of $79.16B. Of 26 analysts, 15 rate the stock Buy or Strong Buy, 9 Hold and 2 Sell or Strong Sell, for a consensus of Hold. Over the last 30 days, 14 estimates for the fiscal year ending Dec 31, 2026 were revised up and 3 down.

    Analyst Ratings

    Scoring Strong Buy as 1 and Strong Sell as 5, the 26 ratings average 2.50, inside the Hold band from 2.5 up to 3.5. Buy and Strong Buy make up 58% of the ratings.

    RatingAnalystsShare
    Strong Buy13.8%
    Buy1453.8%
    Hold934.6%
    Sell13.8%
    Strong Sell13.8%
    Consensus
    Hold
    Total analysts
    26

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Annual Estimates

    From the first fiscal year below to the second, the EPS consensus rises 3.7% and revenue estimates rise 3.2%.

    Fiscal year ending Dec 31, 2026
    $30.16
    EPS consensus, revenue $79.16B
    Fiscal year ending Dec 31, 2027
    $31.28
    EPS consensus, revenue $81.66B
    Next report
    Jan 25, 2027
    Estimated

    EPS range

    Revenue range

    Fiscal year endingEPS consensusEPS rangeEPS analystsRevenue consensusRevenue rangeRev. analysts
    Dec 31, 2026$30.16$29.85 to $30.4318$79.16B$78.63B to $79.48B23
    Dec 31, 2027$31.28$29.83 to $32.5023$81.66B$80.46B to $82.74B22

    Quarterly Estimates

    The EPS consensus falls from $8.28 for the quarter ending Dec 31, 2026 to $7.49 for the quarter ending Mar 31, 2027.

    EPS range

    Revenue range

    Quarter endingEPS consensusEPS rangeEPS analystsRevenue consensusRevenue rangeRev. analysts
    Dec 31, 2026$8.28$7.72 to $8.9424$20.22B$19.30B to $21.30B23
    Mar 31, 2027$7.49$6.93 to $7.9413$19.88B$19.66B to $20.09B12

    Estimate Revisions

    Across the 2 periods below, the last 30 days brought 15 upward and 12 downward EPS revisions.

    PeriodUp 30 daysDown 30 days
    Fiscal year ending Dec 31, 2026143
    Quarter ending Mar 31, 202719

    EPS Trend

    Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has risen 2.0% from $29.56.

    PeriodNow7 days ago30 days ago60 days ago90 days agoChange
    Fiscal year ending Dec 31, 2026$30.16$30.16$29.49$29.49$29.56+2.0%
    Fiscal year ending Dec 31, 2027$31.28$31.29$32.02$32.07$32.16-2.7%
    Quarter ending Mar 31, 2027$7.49$7.52$7.84$7.82$7.81-4.0%

    Frequently Asked Questions About HCA

    What is the HCA stock forecast?

    Consensus analyst estimates put HCA Healthcare's EPS at $30.16 for the fiscal year ending Dec 31, 2026, on revenue of $79.16B. The consensus rating from 26 analysts is Hold.

    How do analysts rate HCA stock?

    Of 26 analysts covering HCA Healthcare, 1 rates it Strong Buy, 14 Buy, 9 Hold, 1 Sell and 1 Strong Sell, for a consensus of Hold.

    What EPS do analysts expect from HCA next year?

    For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is $30.16, with estimates from $29.85 to $30.43 from 18 analysts. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is $31.28, with estimates from $29.83 to $32.50 from 23 analysts.

    What revenue do analysts expect from HCA Healthcare next year?

    For the fiscal year ending Dec 31, 2026, the consensus revenue estimate is $79.16B, with estimates from $78.63B to $79.48B. For the fiscal year ending Dec 31, 2027, the consensus revenue estimate is $81.66B, with estimates from $80.46B to $82.74B.

    How many analysts cover HCA?

    26 analysts rate HCA Healthcare stock, and 18 analysts estimate its EPS for the fiscal year ending Dec 31, 2026.